Don’t Just Focus on the Obvious When Searching for Dividends

Let’s call a spade, a spade. We dividend investors are a particularly boring lot. There’s nothing particularly exciting about sitting back and collecting a check every three months. It’s certainly not as exciting as buying an early-stage biotech drug developer and watching it pass numerous FDA trials.